Drug profile · INN
methoxamine hydrochloride
VASOXYL
methoxamine hydrochloride (VASOXYL) is a adrenergic receptor alpha-1 agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — methoxamine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methoxamine hydrochloride (VASOXYL) is a adrenergic receptor alpha-1 agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-1 agonist
Primary target: Adrenergic receptor alpha-1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methoxamine hydrochloride?
methoxamine hydrochloride (VASOXYL) is a adrenergic receptor alpha-1 agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for methoxamine hydrochloride?
VASOXYL is a marketed brand name for methoxamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methoxamine hydrochloride?
methoxamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.